Yervoi 50 mg Injection
2.589,53$
2.201,16$
Yervoi 50 mg injection is a vital treatment option for adults and adolescents aged 12 and older suffering from advanced melanoma, a critical type of skin cancer. This medication works by enhancing the body’s immune response against cancer cells, promoting the destruction of tumors. Additionally, when combined with nivolumab, Yervoi is effective for various cancers, including advanced renal cell carcinoma, malignant pleural mesothelioma, advanced colorectal cancer, and advanced oesophageal cancer. For adults battling advanced non-small cell lung cancer, Yervoi, in conjunction with nivolumab and chemotherapy, offers a comprehensive treatment approach. While Yervoi presents significant benefits in cancer treatment, patients should be aware of potential immune-related side effects, including inflammation of healthy organs, which require prompt medical attention. It’s essential to discuss individual health conditions and medication history with a healthcare provider before starting Yervoi. With its innovative mechanism and broad application, Yervoi 50 mg injection is transforming cancer care and providing hope to many patients.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Yervoi 50 mg injection is primarily used in the treatment of advanced melanoma, a serious form of skin cancer. This medication works by enhancing the body’s immune response against cancer cells. By targeting specific pathways, Yervoi helps to slow the progression of melanoma and improve patient outcomes. It is typically administered when the melanoma is unresectable or has metastasized.
• Another significant application of Yervoi 50 mg injection is in advanced renal cell carcinoma, which is a type of kidney cancer. The drug aids in activating the immune system to recognize and attack cancer cells in the kidneys. This treatment option is especially valuable for patients with metastatic disease. Clinicians often consider Yervoi for patients who have not responded to other therapies.
• Yervoi 50 mg injection is also utilized in the management of malignant pleural mesothelioma, a cancer affecting the lining of the lungs. This medication can help to stimulate an immune response that targets mesothelioma cells. It is usually part of a comprehensive treatment plan for patients with advanced disease. The goal is to improve survival rates and quality of life in affected individuals.
• Additionally, Yervoi 50 mg injection is indicated for advanced colorectal cancer, which impacts the colon or rectum. By utilizing the body's immune system, this treatment aims to combat cancer progression in patients with advanced disease. It is often used when traditional therapies are insufficient or when the cancer has spread. Physicians may recommend Yervoi as a part of a combination therapy approach.
Benefits
Treatment of metastatic melanoma: Yervoi 50 mg Injection has shown significant benefits in the treatment of advanced melanoma, improving overall survival in patients. It helps shrink tumours and delay disease progression.
Combination therapy: When used in combination with other immunotherapies, such as nivolumab (another immune checkpoint inhibitor that targets PD-1), Yervoi 50 mg has shown improved efficacy compared to when used alone. This combination is particularly effective in treating advanced melanoma and certain types of lung cancer.
Side Effects
Most side effects are temporary and don't need medical attention, usually going away as your body gets used to the medication.If they persist or you're concerned, seek advice from your doctor.
Most Common Side Effects
• Fatigue
• Dizziness
• Tea colored Urine
• Peeling skin
• Tingling sensation in hand and Legs
• Diarrhoea
• Nausea
• Vomiting
• Rash
• Itching
• Chills
Common Side Effects
• Fainting
• Extreme High Fever
• Blurred Vision
• Bleeding and Bruising
• Severe Stomach pain at the right side
• Anorexia
• Fever
• Headache
• Abdominal Pain
• Shorten of Breath
• Coughing
• Anemia
• Tarry stool
• Dry mouth
• Dark Urine
How To Use
Yervoi 50 mg Injection is usually given by a healthcare provider through an intravenous drip. This takes about 90 minutes. The dose depends on the patient's weight, health and the type of cancer being treated. Treatments are often given in cycles, with each cycle consisting of several infusions over a period of weeks or months. If a dose is missed, it's important to contact your healthcare provider immediately to discuss the next steps. The correct timing and frequency of doses is important to get the most benefit from the medicine.
Safety Advice
• Alcohol: Consuming alcohol can harm the immune system and might reduce the effectiveness of cancer treatments. Therefore, it's advised to refrain from alcohol while undergoing treatment with {Produtc_name_two}.
• Kidney: Yervoi 50 mg Injection is considered safe for use in patients with kidney disease, and no adjustment of the dosage is necessary.
• Breastfeeding: It's unclear if Yervoi 50 Injection passes into breast milk. If you're breastfeeding, it's advisable to consult with a healthcare provider before using this medication.
• Liver: Yervoi 50 mg Injection carries a potential risk of immune-related adverse events, such as hepatitis (inflammation of the liver). Patients who already have liver disease may have a higher chance of experiencing these side effects related to the liver.
• Pregnancy: Yervoi 50 mg Injection should be avoided during pregnancy as it may harm the developing baby. Please consult your doctor before using Yervoi 50 mg.
• Driving: Patients who receive Yervoi 50 Injection should be cautioned against driving or operating equipment in the event that they revel in aspect outcomes inclusive of fatigue, dizziness, or blurred vision. These side effects can impair their ability to drive or operate machinery safely.